BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 6, 2002
View Archived Issues
SangStat Prices $77.6M Offering To Pay Off Loan, Stoke Reserves
Read More
Theratechnologies Partners Peptide In Japan With Sakai
Read More
InterMune’s Actimmune Enters Phase III For Ovarian Cancer
Read More
Aphton Raising $17.1M To Finance Clinical Programs
Read More
Other News To Note
Read More
Bush Budget Includes Increases In New Drug Application Fees
WASHINGTON Based on President George Bush’s proposed budget for fiscal year 2003, it appears that biotechnology companies filing drug applications with the FDA will be paying a higher cost. (BioWorld Today)
Read More